頭頸部がん患者における週1回投与パクリタキセル（BMS-181339）の継続投与試験

基本情報

NCT ID

NCT00971867

ステータス

完了

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

11

治験依頼者名

Bristol-Myers Squibb

概要

The purpose of this study is to provide access to paclitaxel therapy to subjects with advanced head and neck cancer who have completed the previous late phase 2 study (CA139-388) and should have continued therapy with paclitaxel as the discretion of the investigator, and to evaluate the frequency and the severity of observed adverse reactions in treated subjects

対象疾患

介入

依頼者（Sponsor）